140 related articles for article (PubMed ID: 36800434)
1. The Clinical Association between
O'Dea AL; Feng R; Glaser LJ; Kubrak C; Rubenstein RC; Dorgan DJ; Hadjiliadis D; Kawut SM; Hong G
Ann Am Thorac Soc; 2023 Jul; 20(7):984-992. PubMed ID: 36800434
[No Abstract] [Full Text] [Related]
2. The presence of Aspergillus fumigatus is associated with worse respiratory quality of life in cystic fibrosis.
Hong G; Alby K; Ng SCW; Fleck V; Kubrak C; Rubenstein RC; Dorgan DJ; Kawut SM; Hadjiliadis D
J Cyst Fibros; 2020 Jan; 19(1):125-130. PubMed ID: 31446018
[TBL] [Abstract][Full Text] [Related]
3. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
Walicka-Serzysko K; Sands D
Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
[TBL] [Abstract][Full Text] [Related]
4. Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis.
Reece E; Segurado R; Jackson A; McClean S; Renwick J; Greally P
BMC Pulm Med; 2017 Apr; 17(1):70. PubMed ID: 28431569
[TBL] [Abstract][Full Text] [Related]
5. Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial.
Lechtzin N; West N; Allgood S; Wilhelm E; Khan U; Mayer-Hamblett N; Aitken ML; Ramsey BW; Boyle MP; Mogayzel PJ; Goss CH
Contemp Clin Trials; 2013 Nov; 36(2):460-9. PubMed ID: 24055998
[TBL] [Abstract][Full Text] [Related]
6. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
Skilton M; Krishan A; Patel S; Sinha IP; Southern KW
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009841. PubMed ID: 30616300
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Aspergillus sensitization or persistent carriage as a factor in lung function impairment in cystic fibrosis patients.
Fillaux J; Brémont F; Murris M; Cassaing S; Rittié JL; Tétu L; Segonds C; Abbal M; Bieth E; Berry A; Pipy B; Magnaval JF
Scand J Infect Dis; 2012 Nov; 44(11):842-7. PubMed ID: 22831545
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Aspergillus fumigatus in patients with cystic fibrosis: a randomized, placebo-controlled pilot study.
Aaron SD; Vandemheen KL; Freitag A; Pedder L; Cameron W; Lavoie A; Paterson N; Wilcox P; Rabin H; Tullis E; Morrison N; Ratjen F
PLoS One; 2012; 7(4):e36077. PubMed ID: 22563440
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and outcomes of oral antibiotic treated pulmonary exacerbations in children with cystic fibrosis.
Hoppe JE; Wagner BD; Accurso FJ; Zemanick ET; Sagel SD
J Cyst Fibros; 2018 Nov; 17(6):760-768. PubMed ID: 29921503
[TBL] [Abstract][Full Text] [Related]
10. The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis.
Amin R; Dupuis A; Aaron SD; Ratjen F
Chest; 2010 Jan; 137(1):171-6. PubMed ID: 19567494
[TBL] [Abstract][Full Text] [Related]
11. Systemic Corticosteroids in the Management of Pediatric Cystic Fibrosis Pulmonary Exacerbations.
Davis CS; Faino AV; Onchiri F; Gibson RL; Merjaneh L; Ramsey BW; Rosenfeld M; Cogen JD
Ann Am Thorac Soc; 2023 Jan; 20(1):75-82. PubMed ID: 36044723
[No Abstract] [Full Text] [Related]
12. Antibiotic Regimen Changes during Cystic Fibrosis Pediatric Pulmonary Exacerbation Treatment.
Cogen JD; Sanders DB; Slaven JE; Faino AV; Somayaji R; Gibson RL; Hoffman LR; Ren CL
Ann Am Thorac Soc; 2023 Sep; 20(9):1293-1298. PubMed ID: 37327485
[No Abstract] [Full Text] [Related]
13. Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum.
Baxter CG; Rautemaa R; Jones AM; Webb AK; Bull M; Mahenthiralingam E; Denning DW
Thorax; 2013 Jul; 68(7):652-7. PubMed ID: 23513028
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and clinical associations of Staphylococcus aureus small-colony variant respiratory infection in children with cystic fibrosis (SCVSA): a multicentre, observational study.
Wolter DJ; Onchiri FM; Emerson J; Precit MR; Lee M; McNamara S; Nay L; Blackledge M; Uluer A; Orenstein DM; Mann M; Hoover W; Gibson RL; Burns JL; Hoffman LR;
Lancet Respir Med; 2019 Dec; 7(12):1027-1038. PubMed ID: 31727592
[TBL] [Abstract][Full Text] [Related]
15. A prospective randomised controlled mixed-methods pilot study of home monitoring in adults with cystic fibrosis.
Nash EF; Choyce J; Carrolan V; Justice E; Shaw KL; Sitch A; Mistry H; Whitehouse JL
Ther Adv Respir Dis; 2022; 16():17534666211070133. PubMed ID: 35274585
[TBL] [Abstract][Full Text] [Related]
16. Serum (1→3)-β-D-glucan and galactomannan levels in patients with cystic fibrosis: a retrospective cohort study.
Träger J; Melichar VO; Meyer R; Rauh M; Bogdan C; Held J
BMC Pulm Med; 2018 Mar; 18(1):52. PubMed ID: 29587700
[TBL] [Abstract][Full Text] [Related]
17. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
[TBL] [Abstract][Full Text] [Related]
18. Aspergillus fumigatus chronic colonization and lung function decline in cystic fibrosis may have a two-way relationship.
Noni M; Katelari A; Dimopoulos G; Doudounakis SE; Tzoumaka-Bakoula C; Spoulou V
Eur J Clin Microbiol Infect Dis; 2015 Nov; 34(11):2235-41. PubMed ID: 26319147
[TBL] [Abstract][Full Text] [Related]
19. Aspergillus Bronchitis in Patients with Cystic Fibrosis.
Brandt C; Roehmel J; Rickerts V; Melichar V; Niemann N; Schwarz C
Mycopathologia; 2018 Feb; 183(1):61-69. PubMed ID: 28819878
[TBL] [Abstract][Full Text] [Related]
20. Aspergillus fumigatus colonization in cystic fibrosis: implications for lung function?
de Vrankrijker AM; van der Ent CK; van Berkhout FT; Stellato RK; Willems RJ; Bonten MJ; Wolfs TF
Clin Microbiol Infect; 2011 Sep; 17(9):1381-6. PubMed ID: 21087348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
